Literature DB >> 28620008

PTEN, DICER1, FH, and Their Associated Tumor Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.

Kris Ann P Schultz1, Surya P Rednam2, Junne Kamihara3, Leslie Doros4, Maria Isabel Achatz5, Jonathan D Wasserman6, Lisa R Diller3, Laurence Brugières7, Harriet Druker8,9, Katherine A Schneider10, Rose B McGee11, William D Foulkes12.   

Abstract

PTEN hamartoma tumor syndrome (PHTS), DICER1 syndrome, and hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome are pleiotropic tumor predisposition syndromes that include benign and malignant neoplasms affecting adults and children. PHTS includes several disorders with shared and distinct clinical features. These are associated with elevated lifetime risk of breast, thyroid, endometrial, colorectal, and renal cancers as well as melanoma. Thyroid cancer represents the predominant cancer risk under age 20 years. DICER1 syndrome includes risk for pleuropulmonary blastoma, cystic nephroma, ovarian sex cord-stromal tumors, and multinodular goiter and thyroid carcinoma as well as brain tumors including pineoblastoma and pituitary blastoma. Individuals with HLRCC may develop multiple cutaneous and uterine leiomyomas, and they have an elevated risk of renal cell carcinoma. For each of these syndromes, a summary of the key syndromic features is provided, the underlying genetic events are discussed, and specific screening is recommended. Clin Cancer Res; 23(12); e76-e82. ©2017 AACRSee all articles in the online-only CCR Pediatric Oncology Series. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28620008     DOI: 10.1158/1078-0432.CCR-17-0629

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  41 in total

1.  Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations.

Authors:  Elke Pfaff; Christian Aichmüller; Martin Sill; Damian Stichel; Matija Snuderl; Matthias A Karajannis; Martin U Schuhmann; Jens Schittenhelm; Martin Hasselblatt; Christian Thomas; Andrey Korshunov; Marina Rhizova; Andrea Wittmann; Anna Kaufhold; Murat Iskar; Petra Ketteler; Dietmar Lohmann; Brent A Orr; David W Ellison; Katja von Hoff; Martin Mynarek; Stefan Rutkowski; Felix Sahm; Andreas von Deimling; Peter Lichter; Marcel Kool; Marc Zapatka; Stefan M Pfister; David T W Jones
Journal:  Acta Neuropathol       Date:  2019-11-25       Impact factor: 17.088

2.  [Genetic risk factors for a second neoplasm in children who have survived a first malignant disease].

Authors:  Martin G Sauer
Journal:  Strahlenther Onkol       Date:  2019-02       Impact factor: 3.621

3.  Genetic Risk for Subsequent Neoplasms Among Long-Term Survivors of Childhood Cancer.

Authors:  Zhaoming Wang; Carmen L Wilson; John Easton; Andrew Thrasher; Heather Mulder; Qi Liu; Dale J Hedges; Shuoguo Wang; Michael C Rusch; Michael N Edmonson; Shawn Levy; Jennifer Q Lanctot; Eric Caron; Kyla Shelton; Kelsey Currie; Matthew Lear; Aman Patel; Celeste Rosencrance; Ying Shao; Bhavin Vadodaria; Donald Yergeau; Yadav Sapkota; Russell J Brooke; Wonjong Moon; Evadnie Rampersaud; Xiaotu Ma; Ti-Cheng Chang; Stephen V Rice; Cynthia Pepper; Xin Zhou; Xiang Chen; Wenan Chen; Angela Jones; Braden Boone; Matthew J Ehrhardt; Matthew J Krasin; Rebecca M Howell; Nicholas S Phillips; Courtney Lewis; Deokumar Srivastava; Ching-Hon Pui; Chimene A Kesserwan; Gang Wu; Kim E Nichols; James R Downing; Melissa M Hudson; Yutaka Yasui; Leslie L Robison; Jinghui Zhang
Journal:  J Clin Oncol       Date:  2018-05-30       Impact factor: 44.544

4.  Neoplasm Risk Among Individuals With a Pathogenic Germline Variant in DICER1.

Authors:  Douglas R Stewart; Ana F Best; Gretchen M Williams; Laura A Harney; Ann G Carr; Anne K Harris; Christian P Kratz; Louis P Dehner; Yoav H Messinger; Philip S Rosenberg; D Ashley Hill; Kris Ann P Schultz
Journal:  J Clin Oncol       Date:  2019-02-04       Impact factor: 44.544

5.  The Future of Surveillance in the Context of Cancer Predisposition: Through the Murky Looking Glass.

Authors:  David Malkin; Kim E Nichols; Joshua D Schiffman; Sharon E Plon; Garrett M Brodeur
Journal:  Clin Cancer Res       Date:  2017-11-01       Impact factor: 12.531

Review 6.  Germline Genetics and Childhood Cancer: Emerging Cancer Predisposition Syndromes and Psychosocial Impacts.

Authors:  Sarah G Mitchell; Bojana Pencheva; Christopher C Porter
Journal:  Curr Oncol Rep       Date:  2019-08-15       Impact factor: 5.075

Review 7.  Imaging of cancer predisposition syndromes.

Authors:  Mary-Louise C Greer
Journal:  Pediatr Radiol       Date:  2018-08-04

Review 8.  Whole-body magnetic resonance imaging: techniques and non-oncologic indications.

Authors:  Mary-Louise C Greer
Journal:  Pediatr Radiol       Date:  2018-08-04

Review 9.  Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.

Authors:  Ugo Testa; Eleonora Petrucci; Luca Pasquini; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2018-02-01

10.  DICER1 Syndrome: Characterization of the Ocular Phenotype in a Family-Based Cohort Study.

Authors:  Laryssa A Huryn; Amy Turriff; Laura A Harney; Ann Garrity Carr; Patricia Chevez-Barrios; Dan S Gombos; Radha Ram; Robert B Hufnagel; D Ashley Hill; Wadih M Zein; Kris Ann P Schultz; Rachel Bishop; Douglas R Stewart
Journal:  Ophthalmology       Date:  2018-10-17       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.